BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$903M |
| 2 |
Apple
AAPL
|
+$854M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$771M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$696M |
| 5 |
Oracle
ORCL
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$1.55B |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$976M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$928M |
| 4 |
AET
Aetna Inc
AET
|
+$832M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.45% |
| 2 | Technology | 14.96% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Smith & Nephew
SNN
$12.5B
| $13.2M | ﹤0.01% |
376,503
-51,689
| -12% | -$1.88M |
|
3002
Utah Medical Products
UTMD
$223M
| $13.2M | ﹤0.01% |
161,775
+3,164
| +2% | +$247K |
|
|
JKS
3003
JinkoSolar
JKS
$847M
| $13.1M | ﹤0.01% |
544,879
+36,176
| +7% | +$910K |
|
3004
IDT Corp
IDT
$1.65B
| $13.1M | ﹤0.01% |
1,460,630
+18,702
| +1% | +$205K |
|
|
MXWL
3005
DELISTED
Maxwell Technologies Inc
MXWL
| $13.1M | ﹤0.01% |
2,266,227
+39,683
| +2% | +$206K |
|
|
AT
3006
DELISTED
Atlantic Power Corporation
AT
| $13M | ﹤0.01% |
5,553,573
-5,324
| -0.1% | -$13.1K |
|
|
BOJA
3007
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $13M | ﹤0.01% |
1,103,664
+41,583
| +4% | +$525K |
|
|
GNMK
3008
DELISTED
GenMark Diagnostics, Inc
GNMK
| $13M | ﹤0.01% |
3,122,412
-269,929
| -8% | -$1.62M |
|
|
RNET
3009
DELISTED
RigNet, Inc.
RNET
| $13M | ﹤0.01% |
870,221
+4,459
| +0.5% | +$72.1K |
|
3010
CRISPR Therapeutics
CRSP
$4.99B
| $13M | ﹤0.01% |
552,558
+549,254
| +16,624% | +$10.4M |
|
|
TREC
3011
DELISTED
Trecora Resources
TREC
| $13M | ﹤0.01% |
960,047
+16,529
| +2% | +$209K |
|
3012
Southern First Bancshares
SFST
$604M
| $12.9M | ﹤0.01% |
313,637
+6,119
| +2% | +$243K |
|
3013
Hurco Companies Inc
HURC
$142M
| $12.9M | ﹤0.01% |
305,928
+6,519
| +2% | +$283K |
|
3014
United States Lime & Minerals
USLM
$3.34B
| $12.9M | ﹤0.01% |
836,065
+3,035
| +0.4% | +$52.3K |
|
3015
Standard BioTools
LAB
$313M
| $12.9M | ﹤0.01% |
2,184,882
+337,639
| +18% | +$1.85M |
|
|
MYOV
3016
DELISTED
Myovant Sciences Ltd.
MYOV
| $12.9M | ﹤0.01% |
1,016,921
+872
| +0.1% | +$11.7K |
|
|
DM
3017
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $12.8M | ﹤0.01% |
421,756
-232,411
| -36% | -$7.31M |
|
3018
Duluth Holdings
DLTH
$158M
| $12.8M | ﹤0.01% |
717,192
+11,413
| +2% | +$211K |
|
3019
Daily Journal
DJCO
$795M
| $12.8M | ﹤0.01% |
55,448
+543
| +1% | +$128K |
|
3020
Weyco Group
WEYS
$419M
| $12.7M | ﹤0.01% |
428,020
-7,172
| -2% | -$202K |
|
|
RLH
3021
DELISTED
Red Lions Hotel Corporation
RLH
| $12.7M | ﹤0.01% |
1,290,678
+15,297
| +1% | +$136K |
|
|
KANG
3022
DELISTED
iKang Healthcare Group, Inc.
KANG
| $12.7M | ﹤0.01% |
801,734
+43,981
| +6% | +$635K |
|
|
GST
3023
DELISTED
Gastar Exploration Inc.
GST
| $12.6M | ﹤0.01% |
12,045,670
+187,454
| +2% | +$163K |
|
|
TLGT
3024
DELISTED
Teligent, Inc
TLGT
| $12.6M | ﹤0.01% |
347,917
-6,606
| -2% | -$316K |
|
3025
Shore Bancshares
SHBI
$805M
| $12.6M | ﹤0.01% |
753,398
+8,705
| +1% | +$149K |
|
Similar funds
BlackRock's Q4 2017 Portfolio in Review
As of Q4 2017, BlackRock held 5,151 positions worth $2.1T, up 6.1% from $1.98T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BlackRock's Q4 2017 filing shows 147 new, 3,054 increased, 1,214 reduced and 177 closed positions. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M. The largest sale was CR Bard Inc., an estimated $1.55B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- BlackRock's largest Q4 2017 buy was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M.
- BlackRock added most to Meta Platforms (Facebook) in Q4 2017, an estimated $903M increase.
- BlackRock's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $928M.
- BlackRock fully exited CR Bard Inc. in Q4 2017, selling an estimated $1.55B.
- BlackRock's ten largest holdings make up 13% of its $2.1T portfolio in Q4 2017.
- BlackRock opened 147 new positions and closed 177 in Q4 2017.
- BlackRock's portfolio value rose 6.1% quarter-over-quarter to $2.1T.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.